Annual report [Section 13 and 15(d), not S-K Item 405]

Investment in account receivable (Details Narrative)

v3.25.1
Investment in account receivable (Details Narrative) - USD ($)
12 Months Ended
Feb. 15, 2022
Apr. 10, 2015
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jun. 11, 2024
Oct. 14, 2023
Jan. 10, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Warrants price per share     $ 0.64 $ 0.64          
Warrants redemption price     $ 0.10            
Impairment of investments         $ (139,148)        
Gain on investments $ 41,930   $ (250,208)          
Annual installment payments                 $ 117,000
Due in 2024                 117,000
Due in 2025                 117,000
Due in 2026                 $ 117,000
Impairment     (250,208)     $ 250,208    
Face value     287,200 [1] 285,400 [1]     287,200    
Unamortized discount     36,992 46,551     $ (36,992)    
Amortization of debt discount     $ 9,559 $ 41,741          
Other Income [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Gain on investments $ (41,930)       $ (41,930) $ 22,718      
Series D Warrants [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Warrants price per share     $ 0.02   $ 1.60     $ 0.02  
Exchange Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Account receivable with annual installment payments   $ 117,000              
Annual installment receivable, term   11 years              
Shares issued, value   $ 1,287,000              
Shares issued, shares   757,059              
Investment in account receivable discount percent       17.87%          
Share price       $ 0.78          
Exchange Agreement [Member] | Series D Warrants [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Warrants issued   757,059              
Warrants price per share   $ 1.60              
Warrants redemption price   $ 0.10              
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.